Get to know Curaleaf better with 10+ real example sentences.
Curaleaf in a sentence
Using Curaleaf
- In the example corpus, curaleaf often appears in combinations such as: of curaleaf, curaleaf to.
Context around Curaleaf
- Average sentence length in these examples: 17.7 words
- Position in the sentence: 8 start, 5 middle, 1 end
- Sentence types: 14 statements, 0 questions, 0 exclamations
Corpus analysis for Curaleaf
- In this selection, "curaleaf" usually appears near the start of the sentence. The average example has 17.7 words, and this corpus slice is mostly made up of statements.
- Around the word, find, europa, based, trades, international and beats stand out and add context to how "curaleaf" is used.
- Recognizable usage signals include cannabis europa curaleaf international brings and ceo of curaleaf a vertically. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "curaleaf" sits close to words such as aaon, abbv and abdalla, which helps place it inside the broader word index.
Example types with curaleaf
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Curaleaf trades at a large premium to the peers. (9 words)
Curaleaf () rose 7% after closing its Acres acquisition in Nevada. (10 words)
Focus on research and development is another reason to like Curaleaf. (11 words)
Stifel Nicolaus decreased their target price on shares of Curaleaf from C$8.50 to C$8.00 in a research report on Wednesday, February 8th. (26 words)
While I find Curaleaf to be likely to rally over the balance of the year, it's not attractive relative to peers in my view. (25 words)
As the Headline Partner for Cannabis Europa, Curaleaf International brings its unparalleled expertise and commitment to advancing the medical cannabis industry in Europe. (23 words)
Example sentences (14)
Curaleaf has a 1 year low of $2.19 and a 1 year high of $7.90.
Curaleaf trades at a large premium to the peers.
Stifel Nicolaus decreased their target price on shares of Curaleaf from C$8.50 to C$8.00 in a research report on Wednesday, February 8th.
While I find Curaleaf to be likely to rally over the balance of the year, it's not attractive relative to peers in my view.
With emerging markets like New Jersey and New York gearing up, Curaleaf’s growth trajectory appears steeply inclined.
As the Headline Partner for Cannabis Europa, Curaleaf International brings its unparalleled expertise and commitment to advancing the medical cannabis industry in Europe.
Curaleaf beats PacificHealth Laboratories on 5 of the 9 factors compared between the two stocks.
Focus on research and development is another reason to like Curaleaf.
Curaleaf CEO Joseph Lusardi said his company has seen a 300 percent increase in demand for medical cannabis products.
Curaleaf () rose 7% after closing its Acres acquisition in Nevada.
Settling with regulators, though, cleared the way for Mass.-based Curaleaf to complete its deal for Cura’s Select brand.
Curaleaf is showing exceptional leverage even prior to scaling and the addition of the Select and Grassroots mergers.
In its email announcement, Curaleaf says patients can place orders online and pick them up in the convenient drive-thru.
Joseph Lusardi is the CEO of Curaleaf, a vertically integrated multi-state cannabis operator headquartered in Wakefield.
Common combinations with curaleaf
These word pairs occur most frequently in English texts:
- of curaleaf 2×
- curaleaf to 2×